Corona Remedies Ltd Board of Directors
Key Highlights
- KIRTIKUMAR LAXMIDAS MEHTA joins the board as Chairman(Non Exe)&Dir(Non-Ind), in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- NIRAVKUMAR KIRTIKUMAR MEHTA joins the board as ED / MD / CEO / Promoter, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- ANKUR KIRTIKUMAR MEHTA joins the board as ED / Joint MD / Promoter, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- VIRAL BHUPENDRABHAI SITWALA joins the board as E D & Wholetime Director, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Ameet Desai joins the board as Independent Non Exe. Director, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Corona Remedies Ltd
NSE: CORONA
Share Price
Last Ten Days Market Price
| Date |  Price (₹) |
|---|---|
| 28 Jul 2026 | 2068.95 |
| 27 Jul 2026 | 2094.05 |
| 24 Jul 2026 | 2114.1 |
| 23 Jul 2026 | 2027.4 |
| 22 Jul 2026 | 2042.6 |
| 21 Jul 2026 | 2089.15 |
| 20 Jul 2026 | 2042.35 |
| 17 Jul 2026 | 2068 |
| 16 Jul 2026 | 2067.25 |
| 15 Jul 2026 | 2064.55 |
Company Fundamentals for Corona Remedies Ltd
Market Cap
12,653 Cr
EPS
32.7
P/E Ratio (TTM)
63.3
P/B Ratio (TTM)
16.9
Day’s High
2129.0
Day’s Low
2071.0
DTE
0.2
ROE
24.8
52 Week High
2139.55
52 Week Low
1336.95
ROCE
27.1
Market Price of Corona Remedies Ltd
1M
1Y
3Y
5Y
Monitoring Corona Remedies Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
Corona Remedies Ltd News Hub
Corona Remedies to announce Quarterly Result
Corona Remedies will hold a meeting of the Board of Directors of the Company on 31 July 2026.
Read more
18 Jul 26
Shares of Corona Remedies list in B group
The equity shares of Corona Remedies (Scrip Code: 544644) are listed effective 15 December 2025 and
Read more
15 Dec 25
Corona Remedies Q2 PAT climbs 22% YoY to Rs 52 cr
Profit before tax (PBT) increased 21.67% year on year (YoY) to Rs 69.78 crore in Q2 FY26. Earnings B
Read more
03 Jan 26
Corona Remedies gains as Q2 PAT climbs 22% YoY to Rs 52 cr
Profit before tax (PBT) increased 21.67% year on year (YoY) to Rs 69.78 crore in Q2 FY26. Earnings B
Read more
05 Jan 26
Document
Annual Reports
N/A
Credit Ratings
N/A
Concalls
Data not available
Data not available
Popular Search
FAQs for Board of Directors of Corona Remedies Ltd
How are members of Corona Remedies Ltd Board of Directors selected?
Members of the Corona Remedies Ltd Board of Directors are typically selected based on their expertise, experience, and alignment with Corona Remedies Ltd’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.
Can shareholders interact with the Corona Remedies Ltd Board of Directors?
Shareholders can interact with the Corona Remedies Ltd Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.
How often does the Corona Remedies Ltd Board of Directors meet?
The Corona Remedies Ltd Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.
What are the responsibilities of the Corona Remedies Ltd Board of Directors?
The Corona Remedies Ltd Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.
Who are the current members of the Board of Directors at Corona Remedies Ltd?
The current Board of Directors at Corona Remedies Ltd includes KIRTIKUMAR LAXMIDAS MEHTA( Chairman(Non Exe)&Dir(Non-Ind)) ,NIRAVKUMAR KIRTIKUMAR MEHTA( ED / MD / CEO / Promoter) ,ANKUR KIRTIKUMAR MEHTA( ED / Joint MD / Promoter) ,VIRAL BHUPENDRABHAI SITWALA( E D & Wholetime Director) ,Ameet Desai( Independent Non Exe. Director) . The full list can be found on Corona Remedies Ltd’s official website or recent corporate filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
